These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21637343)

  • 1. Vascular endothelial growth factor in the circulation in cancer patients may not be a relevant biomarker.
    Niers TM; Richel DJ; Meijers JC; Schlingemann RO
    PLoS One; 2011; 6(5):e19873. PubMed ID: 21637343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shift in the balance between circulating thrombospondin-1 and vascular endothelial growth factor in cancer patients: relationship to platelet alpha-granule content and primary activation.
    Gonzalez FJ; Rueda A; Sevilla I; Alonso L; Villarreal V; Torres E; Alba E
    Int J Biol Markers; 2004; 19(3):221-8. PubMed ID: 15503824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF levels in plasma in relation to platelet activation, glycemic control, and microvascular complications in type 1 diabetes.
    Schlingemann RO; Van Noorden CJ; Diekman MJ; Tiller A; Meijers JC; Koolwijk P; Wiersinga WM
    Diabetes Care; 2013 Jun; 36(6):1629-34. PubMed ID: 23321217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis.
    Solanilla A; Villeneuve J; Auguste P; Hugues M; Alioum A; Lepreux S; Ducroix JP; Duhaut P; Conri C; Viallard JF; Nurden AT; Constans J; Ripoche J
    Rheumatology (Oxford); 2009 Sep; 48(9):1036-44. PubMed ID: 19549789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
    Salven P; Orpana A; Joensuu H
    Clin Cancer Res; 1999 Mar; 5(3):487-91. PubMed ID: 10100697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo?
    Wynendaele W; Derua R; Hoylaerts MF; Pawinski A; Waelkens E; de Bruijn EA; Paridaens R; Merlevede W; van Oosterom AT
    Ann Oncol; 1999 Aug; 10(8):965-71. PubMed ID: 10509160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
    George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
    Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen?
    Lee JK; Hong YJ; Han CJ; Hwang DY; Hong SI
    Int J Oncol; 2000 Jul; 17(1):149-52. PubMed ID: 10853032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of angiogenesis regulatory proteins and epithelial-mesenchymal transition factors in platelets of the breast cancer patients.
    Han H; Cao FL; Wang BZ; Mu XR; Li GY; Wang XW
    ScientificWorldJournal; 2014; 2014():878209. PubMed ID: 25379550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation determines angiopoietin-1 and VEGF levels in malaria: implications for their use as biomarkers.
    Brouwers J; Noviyanti R; Fijnheer R; de Groot PG; Trianty L; Mudaliana S; Roest M; Syafruddin D; van der Ven A; de Mast Q
    PLoS One; 2014; 8(6):e64850. PubMed ID: 23755151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets.
    Etulain J; Mena HA; Negrotto S; Schattner M
    Platelets; 2015; 26(8):799-804. PubMed ID: 26082997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients.
    Engels EA; Jennings L; Kemp TJ; Chaturvedi AK; Pinto LA; Pfeiffer RM; Trotter JF; Acker M; Onaca N; Klintmalm GB
    Cancer Med; 2015 Aug; 4(8):1252-7. PubMed ID: 25919050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments.
    Dittadi R; Meo S; Fabris F; Gasparini G; Contri D; Medici M; Gion M
    Int J Biol Markers; 2001; 16(2):87-96. PubMed ID: 11471901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients.
    Benoy I; Salgado R; Colpaert C; Weytjens R; Vermeulen PB; Dirix LY
    Clin Breast Cancer; 2002 Jan; 2(4):311-5. PubMed ID: 11899364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of serum hepatocyte growth factor in clear cell renal cell carcinoma: comparison with serum vascular endothelial growth factor.
    Tanimoto S; Fukumori T; El-Moula G; Shiirevnyamba A; Kinouchi S; Koizumi T; Nakanishi R; Yamamoto Y; Taue R; Yamaguchi K; Nakatsuji H; Kishimoto T; Izaki H; Oka N; Takahashi M; Kanayama HO
    J Med Invest; 2008 Feb; 55(1-2):106-11. PubMed ID: 18319552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased TGF-β1 and VEGF Release in Cystic Fibrosis Platelets: Further Evidence for Platelet Defects in Cystic Fibrosis.
    Maloney JP; Narasimhan J; Biller J
    Lung; 2016 Oct; 194(5):791-8. PubMed ID: 27423781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.
    Schips L; Dalpiaz O; Lipsky K; Langner C; Rehak P; Puerstner P; Pummer K; Zigeuner R
    Eur Urol; 2007 Jan; 51(1):168-73; discussion 174. PubMed ID: 16844285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients.
    Peterson JE; Zurakowski D; Italiano JE; Michel LV; Connors S; Oenick M; D'Amato RJ; Klement GL; Folkman J
    Angiogenesis; 2012 Jun; 15(2):265-73. PubMed ID: 22402885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenib.
    Desar IM; Stillebroer AB; Oosterwijk E; Leenders WP; van Herpen CM; van der Graaf WT; Boerman OC; Mulders PF; Oyen WJ
    J Nucl Med; 2010 Nov; 51(11):1707-15. PubMed ID: 20956472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma.
    Caine GJ; Lip GY; Stonelake PS; Ryan P; Blann AD
    Thromb Haemost; 2004 Jul; 92(1):185-90. PubMed ID: 15213860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.